Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$16.31
-3.38%
Mkt Cap $1.44B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | -$52.00K | — | — | -$0.31 | -$0.30 | +3.23% | — | — |
| Q4 2025 Nov 6, 2025 | $52.00K | — | — | -$0.43 | -$0.37 | +13.95% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.44 | -$0.46 | -4.55% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.45 | -$0.42 | +6.67% | — | — |
| Q1 2025 Mar 4, 2025 | — | $665.00K | — | -$0.49 | -$0.55 | -12.24% | — | — |
| Q4 2024 Nov 7, 2024 | — | $416.00K | — | -$0.47 | -$0.53 | -12.77% | — | — |
| Q3 2024 Aug 8, 2024 | $10.66M | $1.02M | -90.41% | -$0.38 | -$0.73 | -92.11% | — | — |
| Q2 2024 May 9, 2024 | $98.35M | $88.64M | -9.87% | $0.24 | -$0.46 | -291.67% | — | — |
| Q1 2024 Feb 22, 2024 | $106.96M | $108.45M | +1.39% | $0.23 | $0.07 | -69.57% | — | — |
| Q4 2023 Nov 9, 2023 | $107.85M | $102.69M | -4.78% | $0.44 | $0.30 | -31.82% | — | — |
| Q3 2023 Aug 10, 2023 | $92.11M | $98.22M | +6.63% | $0.10 | $0.31 | +210.00% | — | — |
| Q2 2023 May 11, 2023 | $87.61M | $71.43M | -18.47% | -$0.24 | $0.02 | +108.33% | — | — |
| Q1 2023 Mar 13, 2023 | $58.99M | $21.89M | -62.90% | -$0.77 | -$0.65 | +15.58% | — | — |
| Q4 2022 Nov 10, 2022 | $83.33K | $345.00K | +314.00% | -$0.97 | -$0.92 | +5.15% | — | — |
| Q3 2022 Aug 11, 2022 | $125.00K | — | — | -$0.92 | -$0.93 | -1.09% | — | — |
| Q2 2022 May 12, 2022 | $83.33K | — | — | -$0.75 | -$0.93 | -24.00% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.64 | -$4.15 | -548.44% | — | — |
| Q1 2022 Jan 10, 2022 | — | $285.00K | — | — | -$0.42 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.48 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.32 | — | — | — |